Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Steven, Dubinett"'
Publikováno v:
Seminars in Oncology. 49:306-318
Unleashing the immune system to fight cancer has been a major breakthrough in cancer therapeutics since 2014 when anti-PD-1 antibodies (pembrolizumab and nivolumab) were approved for patients with metastatic melanoma. Therapeutic indications have rap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eef13ab68c5c29fc9b37a0ea5afef7a
https://doi.org/10.1053/j.seminoncol.2022.06.005
https://doi.org/10.1053/j.seminoncol.2022.06.005
Autor:
Avrum Spira, Marc E. Lenburg, Duncan Whitney, Kate Smith, Steven Dubinett, David Elashoff, Gang Liu, Joshua D. Campbell, Ana B. Pavel
Supplementary Figure 1. Principal Components Analysis (PCA) of global microRNA expression. Supplementary Figure 2. Significantly differentially expressed microRNAs between current and former smokers (q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34fd6c91c22d66bd5dcf53dd1c4c3b4b
https://doi.org/10.1158/1940-6207.22532881.v1
https://doi.org/10.1158/1940-6207.22532881.v1
Supplementary Data from p120-Catenin Is Transcriptionally Downregulated by FOXC2 in Non–Small Cell Lung Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4286a396f7f424a632475799b173089f
https://doi.org/10.1158/1541-7786.22519345.v1
https://doi.org/10.1158/1541-7786.22519345.v1
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a307601d2160103eafd1495949141b22
https://doi.org/10.1158/1078-0432.22474590
https://doi.org/10.1158/1078-0432.22474590
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplementary Table Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5138f4395cc71838ec71dedb3912974e
https://doi.org/10.1158/1078-0432.22474584
https://doi.org/10.1158/1078-0432.22474584
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplemental Figure 1. Schematic presentation of the analyzed parameters in the correlative cohort per progression survival (PFS). TMB: total mutational burden. PR: partial response. SD: stable disease. PD: progressive disease. â-³: mutation. Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b89a8af93b3d7203be941dd8e3cdd93
https://doi.org/10.1158/1078-0432.22474587
https://doi.org/10.1158/1078-0432.22474587
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Purpose:Several biomarkers have been individually associated with response to PD-1 blockade, including PD-L1 and tumor mutational burden (TMB) in non–small cell lung cancer (NSCLC), and CD8 cells in melanoma. We sought to examine the relationship b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e0f397fda69c30f797882bbb41ddfb
https://doi.org/10.1158/1078-0432.c.6528828
https://doi.org/10.1158/1078-0432.c.6528828
Autor:
Claudio Scafoglio, Gihad Abdelhady, Jie Liu, Jane Yanagawa, Dean Wallace, Jorge Barrio, Steven Dubinett, David Shackelford
Publikováno v:
Journal of Clinical and Translational Science, Vol 2, Pp 27-28 (2018)
OBJECTIVES/SPECIFIC AIMS: Lung cancer claims 160,000 lives in the United States every year, and lung adenocarcinoma (LADC) is the most frequent type. Early diagnosis is crucial. Computed tomography (CT) is very sensitive in identifying early-stage lu
Externí odkaz:
https://doaj.org/article/1361de204d314932a361ee7640c1113e
Autor:
William P. Crosson, Rui Li, Ramin Salehi-Rad, Raymond J. Lim, Jensen Abascal, Bitta P. Kahangi, Edgar Perez Reyes, Michael Oh, Camelia Dumitras, Nico Edgar, Ryan Chew, Rashel Jacobo, Zhe Jing, Kostyantyn Krysan, Linh M. Tran, Steven Dubinett, Bin Liu
Publikováno v:
Cancer Research. 83:5157-5157
Lung cancer remains the deadliest form of cancer, claiming the lives of 1.8 million individuals worldwide in 2020. While treatment options have improved with the advent of immune checkpoint inhibitors (ICI), many patients do not respond to immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df12e8db4945b4d9c33892603e10ec39
https://doi.org/10.1158/1538-7445.am2023-5157
https://doi.org/10.1158/1538-7445.am2023-5157
Autor:
Pasquale Saggese, Aparamita Pandey, Eileen Fung, Jane Yanagawa, Erika F. Rodriguez, Tristan R. Grogan, Giorgio Giurato, Giovanni Nassa, Annamaria Salvati, Alessandro Weisz, Steven Dubinett, Claudio Scafoglio
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a48f6c9598542f91a37a85c5cc855acc
https://doi.org/10.2139/ssrn.4124636
https://doi.org/10.2139/ssrn.4124636